Literature DB >> 16357462

Successful treatment with tacrolimus in a case of refractory dermatomyositis.

Takao Mitsui1, Yukiko Kuroda, Makoto Kunishige, Toshio Matsumoto.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16357462     DOI: 10.2169/internalmedicine.44.1197

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


× No keyword cloud information.
  6 in total

1.  The association between dermatomyositis and papillary thyroid cancer: a case report.

Authors:  Tokunori Ikeda; En Kimura; Teruyuki Hirano; Makoto Uchino
Journal:  Rheumatol Int       Date:  2011-01-18       Impact factor: 2.631

Review 2.  Effects of tacrolimus on dermatomyositis and polymyositis: a prospective, open, non-randomized study of nine patients and a review of the literature.

Authors:  Shiro Matsubara; Koichi Kondo; Keizo Sugaya; Kazuhito Miyamoto
Journal:  Clin Rheumatol       Date:  2012-08-12       Impact factor: 2.980

3.  Treatment of refractory juvenile dermatomyositis with tacrolimus.

Authors:  Jihaan Hassan; Jan Jaap van der Net; Annet van Royen-Kerkhof
Journal:  Clin Rheumatol       Date:  2008-08-21       Impact factor: 2.980

Review 4.  Immune mechanisms in the pathogenesis of idiopathic inflammatory myopathies.

Authors:  Cecilia Grundtman; Vivianne Malmström; Ingrid E Lundberg
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

5.  Tacrolimus-Induced Remission in Drug Resistant Inflammatory Myopathy: A Case Series.

Authors:  Karina Rotella; Milena Rodriguez Alvarez; Yair Saperstein; Manjeet S Bhamra; Su Zhaz Leon; Alekznder Feoktiztov; Isabel M McFarlane
Journal:  Rheumatology (Sunnyvale)       Date:  2018-05-31

6.  Coadministration of tacrolimus with corticosteroid accelerates recovery in refractory patients with polymyositis/ dermatomyositis: a retrospective study.

Authors:  Yasuhiro Shimojima; Wataru Ishii; Masayuki Matsuda; Ko-ichi Tazawa; Shu-ichi Ikeda
Journal:  BMC Musculoskelet Disord       Date:  2012-11-22       Impact factor: 2.362

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.